NextCODE Health Launches Operations with Exclusive License to Leverage deCODE genetics' Genomics Platform for Sequence-Based Clinical Diagnostics, and $15 Million in Venture Financing CAMBRIDGE, Mass.
SAN FRANCISCO, Jan. 10, 2012 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced it is taking orders for the new benchtop Ion Proton TM Sequencer that is designed to sequence ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback